Augmented renal clearance (ARC) is common in trauma patients and associated with subtherapeutic antimicrobial concentrations. This study reported the incidence of ARC, identified ARC risk factors and described a model to predict ARC (i.e.,ARCTIC) that is specific to trauma patients.
Consecutive trauma patients who were admitted to the ICU between March 2015 and January 2016 and had a measured creatinine clearance (CrCl) were considered for inclusion. Patients were excluded if their serum creatinine (SCr) was >1.3 mg/dL. ARC was defined as a measured CrCl ≥130ml/min. Demographic and trauma-specific variables were then compared and multivariate analysis was performed. Using these results, a weighted scoring system was constructed and evaluated using receiver operating characteristic (ROC) curve analysis. ARCTIC score cut-offs were chosen based on sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV). The derived scoring system was then compared to a previously published scoring system for accuracy.
There were 133 patients with a mean age of 48±19 years and SCr of 0.8±0.2 mg/dL. The mean measured CrCl was 168±65 ml/min and the incidence of ARC was 67%. Multivariate analysis revealed the following risk factors for ARC [odds ratios (95% CI)]: age <56 [58.3(5.2-658.9), age 56 to 75 [13.5(1.2-151.7)], SCr<0.7mg/dL [12.5(3-52.6)] and male gender [6.9(1.9-24.9)]. Using these results, the ARCTIC scoring system was: 4 points if age <56, 3 points if age 57-75, 3 points if SCr <0.7 mg/dL and 2 points if male gender. ROC curve analysis revealed an area (95% CI) of 0.813(0.735-0.892), p<.001. An ARCTIC score of ≥ 6 had a sensitivity, specificity, PPV and NPV of 0.843, 0.682, 0.843 and 0.682, respectively.
The incidence of ARC in trauma patients is high. The ARCTIC score represents a practical, pragmatic system that can be easily applied at the bedside. An ARCTIC score ≥6 represents an appropriate cut-off to screen for ARC where antimicrobial adjustments should be considered.
Prognostic and epidemiologic study, level III.